Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01744223
Title Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bellicum Pharmaceuticals
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

lymphoma

Therapies

Rimiducid

Rivogenlecleucel

Age Groups: adult
Covered Countries USA


No variant requirements are available.